Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $144.45 USD
Change Today 0.00 / 0.00%
Volume 0.0
LZAGF On Other Exchanges
SIX Swiss Ex
As of 8:10 PM 10/19/15 All times are local (Market data is delayed by at least 15 minutes).

lonza group ag-reg (LZAGF) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/10/15 - $146.69
52 Week Low
01/20/15 - $105.36
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for LONZA GROUP AG-REG (LZAGF)

Related News

No related news articles were found.

lonza group ag-reg (LZAGF) Related Businessweek News

View More BusinessWeek News

lonza group ag-reg (LZAGF) Details

Lonza Group Ltd. supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Specialty Ingredients and Pharma&Biotech. The Specialty Ingredients segment offers consumer care products comprising actives for antidandruff shampoos, and natural and organic cosmetic ingredients; vitamin B compounds; and microbial control solutions, including disinfectants and sanitizers that protect from dangerous and unwanted microbes. This segment also provides custom agricultural manufacturing services to enhance crop yields and food quality; industrial Solutions, including preservatives and biocide blends; products and services that enhance the quality of wood; and sanitizers and other treatment chemicals for pools, spas, water parks, as well as in the treatment of surface waters for drinking, agriculture, irrigation, food processing, and industrial applications. The Pharma&Biotech segment develops and manufactures active pharmaceutical ingredients (APIs) for drug companies; microbial parenteral API, including antibody fragments, vaccines, cytokines, plasmid DNA, fusion proteins, and PEGylated products; and chemical custom services, such as chemically derived active ingredients, peptide syntheses, antibody drug conjugates, cytotoxic, and small organic molecules. It also offers cell culture, transfection, and molecular biology tools for life-science research; media used in the production of therapeutics; endotoxin detection assays; and products and services targeting cardiovascular, respiratory, neurological, metabolic, cancer, and other disease research areas. This segment serves customers in academic and government institutions, and in biotech and pharmaceutical organizations. Lonza Group Ltd. was founded in 1897 and is headquartered in Basel, Switzerland.

9,721 Employees
Last Reported Date: 07/22/15
Founded in 1897

lonza group ag-reg (LZAGF) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: SFr.1.3M
Compensation as of Fiscal Year 2014.

lonza group ag-reg (LZAGF) Key Developments

Lonza Group Ltd. Provides Earning Guidance for the Full Year 2015

Lonza Group Ltd. provided earning guidance for the full year 2015. Based on constant exchange rates and taking into consideration the bi-yearly cracker shut-down in Visp (CH) in fourth quarter 2015, Lonza is confident that it will deliver sales growth in 2015. Lonza is planning for CORE EBIT growth of above 5% as a result of portfolio optimizations and further operational productivity improvements. Ongoing enhancements of the worldwide production network are expected to lead to a further improved CORE RONOA of above 15%.

Lonza Group Ltd, Q3 2015 Earnings Call, Oct 29, 2015

Lonza Group Ltd, Q3 2015 Earnings Call, Oct 29, 2015

Lonza Group Signs Commercial Collaboration Agreement with Lamberti SpA

Lonza Group has announced that its consumer care business unit has signed a long-term commercial collaboration agreement with Lamberti SpA, under which Lonza will have access to Lamberti's portfolio of hair care, personal care and home care products for sale in South America. Lonza and its regional customers will benefit from complementary technologies, such as Lamberti's natural hair-conditioning polymers, which add to the already extensive Lonza Consumer Care portfolio. Based in Italy, Lamberti will benefit from Lonza's existing infrastructure, customer relationships and sales and technical support teams in Brazil, Argentina and other countries in South America.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LZAGF:US $144.45 USD 0.00

LZAGF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ashland Inc $112.31 USD +0.16
Celanese Corp $71.37 USD +0.70
Dr Reddy's Laboratories Ltd 3,388 INR -21.55
EMS-Chemie Holding AG SFr.417.25 CHF +6.00
Owens Corning $47.42 USD -0.33
View Industry Companies

Industry Analysis


Industry Average

Valuation LZAGF Industry Range
Price/Earnings 36.9x
Price/Sales 2.0x
Price/Book 3.9x
Price/Cash Flow 37.3x
TEV/Sales 1.5x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact LONZA GROUP AG-REG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at